Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
Authors
Keywords
Pancreatic Cancer, Pancreatic Cancer Patient, Pancreas Cancer, Immune Checkpoint Inhibitor, Survivin Peptide
Journal
Journal of Hematology & Oncology
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-07
DOI
10.1186/s13045-017-0459-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2
- (2016) Julia M. Greene et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lessons learned from cancer vaccine trials and target antigen choice
- (2016) Lisa H. Butterfield CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
- (2016) K. F. Bol et al. CLINICAL CANCER RESEARCH
- Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
- (2016) Zibing Wang et al. Journal of Hematology & Oncology
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
- (2016) Daniel Delitto et al. PHARMACOLOGY & THERAPEUTICS
- Antitumor dendritic cell–based vaccines: lessons from 20 years of clinical trials and future perspectives
- (2016) João Constantino et al. Translational Research
- Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation
- (2016) Angus W. Thomson et al. Frontiers in Immunology
- Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer
- (2015) Hai-Bo Xi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
- (2015) Jeong-Hoon Lee et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
- (2015) Shuhei Mayanagi et al. CANCER SCIENCE
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Advances in the management of gastrointestinal cancers—an upcoming role of immune checkpoint blockade
- (2015) Gaurav Goel et al. Journal of Hematology & Oncology
- Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future
- (2015) Gaurav Goel et al. Journal of Hematology & Oncology
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation
- (2015) Alexander M. Lesokhin et al. Science Translational Medicine
- DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift
- (2015) Anna L. de Goede et al. VACCINE
- New targeted therapies in pancreatic cancer
- (2015) Andrada Seicean WORLD JOURNAL OF GASTROENTEROLOGY
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
- (2015) Michal Podrazil et al. Oncotarget
- Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients
- (2015) Sara Nava et al. Stem Cells Translational Medicine
- Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models
- (2015) Soledad Mac Keon et al. Frontiers in Immunology
- Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
- (2015) Kalijn F Bol et al. OncoImmunology
- Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
- (2015) Aintzane Zabaleta et al. Molecular Therapy-Methods & Clinical Development
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia
- (2014) Marion Subklewe et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease
- (2014) Davide Melisi et al. CURRENT PHARMACEUTICAL DESIGN
- Vaccine adjuvant uses of poly-IC and derivatives
- (2014) Karen AO Martins et al. Expert Review of Vaccines
- Promising new therapies in advanced pancreatic adenocarcinomas
- (2014) Madappa Kundranda et al. Future Oncology
- Dendritic Cell-Derived Exosomes as Immunotherapies in the Fight against Cancer
- (2014) J. M. Pitt et al. JOURNAL OF IMMUNOLOGY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Recent advances and new opportunities for targeting human dendritic cells in situ
- (2014) Madhav V Dhodapkar et al. OncoImmunology
- A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
- (2014) Hirokazu Matsushita et al. Journal for ImmunoTherapy of Cancer
- Inflammatory networks and immune surveillance of pancreatic carcinoma
- (2013) Robert H Vonderheide et al. CURRENT OPINION IN IMMUNOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?
- (2013) Lisa H. Butterfield Frontiers in Immunology
- Decisions About Dendritic Cells: Past, Present, and Future
- (2012) Ralph M. Steinman Annual Review of Immunology
- The Receptor for Advanced Glycation End Products Promotes Pancreatic Carcinogenesis and Accumulation of Myeloid-Derived Suppressor Cells
- (2012) P. J. Vernon et al. JOURNAL OF IMMUNOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
- (2010) Karolina Palucka et al. IMMUNITY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)
- (2009) M. L. Salem et al. JOURNAL OF IMMUNOLOGY
- Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals
- (2008) Vaios Karanikas et al. CLINICAL IMMUNOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now